SAB Biotherapeutics, Inc.
NASDAQ:SABS
2.74 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||
Current Assets: | |||||||||||||||
Cash & Cash Equivalents
| 17.242 | 14.034 | 56.566 | 2.425 | 7.774 | 13.06 | 15.047 | 8.332 | 16.616 | 22.408 | 33.207 | 0.668 | 10.233 | 0.858 | 12.61 |
Short Term Investments
| 20.084 | 30.023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 37.326 | 44.057 | 56.566 | 2.425 | 7.774 | 13.06 | 15.047 | 8.332 | 16.616 | 22.408 | 33.207 | 0.668 | 10.233 | 0.858 | 12.61 |
Net Receivables
| 0.225 | 0.193 | 0 | 0 | 0.364 | 0.763 | 5.557 | 12.942 | 9.613 | 11.786 | 8.011 | 0 | 17.109 | 0 | 20.569 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 2.03 | 2.701 | 2.341 | 0.702 | 0.868 | 1.209 | 1.494 | 0.908 | 1.521 | 1.975 | 7.203 | 0.103 | 0.427 | 0.263 | 1.275 |
Total Current Assets
| 39.58 | 46.951 | 58.907 | 3.128 | 9.006 | 15.032 | 22.097 | 22.182 | 27.751 | 36.17 | 48.42 | 0.771 | 27.769 | 1.121 | 34.455 |
Non-Current Assets: | |||||||||||||||
Property, Plant & Equipment, Net
| 21.79 | 22.631 | 24.684 | 24.837 | 26.002 | 27.206 | 28.34 | 29.824 | 30.869 | 31.303 | 30.949 | 0 | 26.443 | 0 | 22.083 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 1.235 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 116.158 | 116.155 | 116.152 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.522 | 0.554 | 0.35 | 0.371 | 0.434 | 0.434 | 0.468 | 0.501 | 0.535 | 0 | 0 | 0 | -116.155 | 0 | 0 |
Total Non-Current Assets
| 22.311 | 24.42 | 25.034 | 25.209 | 26.436 | 27.64 | 28.807 | 30.325 | 31.404 | 31.303 | 30.949 | 116.158 | 26.443 | 116.152 | 22.083 |
Total Assets
| 61.892 | 71.371 | 83.941 | 28.336 | 35.443 | 42.672 | 50.905 | 52.507 | 59.155 | 67.472 | 79.369 | 116.929 | 54.212 | 117.273 | 56.538 |
Liabilities & Equity: | |||||||||||||||
Current Liabilities: | |||||||||||||||
Account Payables
| 1.171 | 1.24 | 0.946 | 1.083 | 1.404 | 1.445 | 3.679 | 5.484 | 4.944 | 4.981 | 4.459 | 0 | 5.498 | 0 | 7.382 |
Short Term Debt
| 1.212 | 1.513 | 1.853 | 1.2 | 0.785 | 1.095 | 1.396 | 1.379 | 1.335 | 1.326 | 1.328 | 0 | 1.16 | 0 | 1.658 |
Tax Payables
| 0 | 0 | 0.04 | 0.03 | 0.02 | 0.05 | 0.05 | 0.083 | 0.033 | 0.142 | 0.216 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0.115 | 0.378 | 1.322 | 1.627 | 2.895 | 2.939 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0.1 | 0 | 0.1 |
Other Current Liabilities
| 5.054 | 5.174 | 6.692 | 5.3 | 5.928 | 8.186 | 9.918 | 10.238 | 9.859 | 11.949 | 18.797 | 0.322 | 3.438 | 0.08 | 1.922 |
Total Current Liabilities
| 7.552 | 8.305 | 10.813 | 9.211 | 11.011 | 13.666 | 14.993 | 17.101 | 16.137 | 18.256 | 24.684 | 0.322 | 10.197 | 0.08 | 11.062 |
Non-Current Liabilities: | |||||||||||||||
Long Term Debt
| 4.131 | 3.938 | 4.054 | 3.452 | 4.119 | 4.365 | 4.533 | 4.425 | 4.756 | 5.088 | 5.416 | 0 | 5.757 | 0 | 6.468 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 4.089 | 6.306 | 11.774 | 0.417 | 0.596 | 0.238 | 0.321 | 0.358 | 1.14 | 2.871 | 10.72 | 9.75 | 0 | 7.803 | 0 |
Total Non-Current Liabilities
| 8.22 | 10.244 | 15.828 | 3.87 | 4.715 | 4.604 | 4.853 | 4.783 | 5.896 | 7.958 | 16.136 | 9.75 | 5.757 | 7.803 | 6.468 |
Total Liabilities
| 15.772 | 18.549 | 26.642 | 13.08 | 15.726 | 18.269 | 19.847 | 21.884 | 22.034 | 26.214 | 40.819 | 10.072 | 15.953 | 7.883 | 17.53 |
Equity: | |||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.002 | 0 | 0.002 |
Common Stock
| 0.001 | 0.001 | 0.001 | 0.005 | 0.005 | 0.005 | 0.005 | 0.004 | 0.004 | 0.004 | 0.004 | 116.15 | 0.004 | 104.39 | 0.004 |
Retained Earnings
| -102.425 | -95.089 | -90.064 | -67.207 | -62.104 | -55.224 | -47.87 | -39.995 | -32.919 | -28.143 | -29.129 | -9.294 | -13.516 | 2.964 | -11.984 |
Accumulated Other Comprehensive Income/Loss
| -0.031 | -0.063 | 0.026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 148.575 | 147.973 | 147.336 | 82.457 | 81.816 | 79.621 | 78.923 | 70.614 | 70.036 | 69.397 | 67.675 | 0 | 51.769 | 2.035 | 50.987 |
Total Shareholders Equity
| 46.12 | 52.822 | 57.299 | 15.256 | 19.716 | 24.403 | 31.058 | 30.623 | 37.121 | 41.258 | 38.55 | 106.857 | 38.259 | 109.39 | 39.008 |
Total Equity
| 46.12 | 52.822 | 57.299 | 15.256 | 19.716 | 24.403 | 31.058 | 30.623 | 37.121 | 41.258 | 38.55 | 106.857 | 38.259 | 109.39 | 39.008 |
Total Liabilities & Shareholders Equity
| 61.892 | 71.371 | 83.941 | 28.336 | 35.443 | 42.672 | 50.905 | 52.507 | 59.155 | 67.472 | 79.369 | 116.929 | 54.212 | 117.273 | 56.538 |